Best Thyroid function tests (including T3, T4, TSH) doctors in Istanbul: TOP 38 doctors

Dr. Mustafa Solak is a medical oncologist with expertise in breast, testicular, ovarian, lung, head-neck, and gastrointestinal cancers. He graduated from Hacettepe University School of Medicine. He completed his residency at Istanbul Sisli Etfal Teaching and Research Hospital. He then pursued a fellowship at Hacettepe University Cancer Institute.

Dr. Solak has managed many complex cancer cases. He has contributed to clinical advancements at respected centers, including the University of Texas MD Anderson Cancer Center. He has also worked at Hitit University Corum Training Hospital and Medical Park Hospital. His experience shows a strong commitment to cancer care and research.

Dr. Nuri Alper Sahbaz is an experienced endocrine and general surgeon. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine. He also gained advanced clinical experience at Baylor College of Medicine and The University of Texas Medical School. He holds the European Board of Endocrine Surgery Qualification. Only five surgeons in Turkey have this accreditation.

Dr. Sahbaz focuses on surgeries of the thyroid, parathyroid, adrenal gland, and neuroendocrine tumors. He is skilled in laparoscopic and minimally invasive procedures. He has performed more than 2,000 surgeries in these areas. He is also known for his expertise in diagnostic and therapeutic gastrointestinal endoscopy.

Assoc. Prof. Dr. Suleyman Hilmi Ipekci, M.D., is an experienced endocrinologist. He specializes in diabetes, thyroid diseases, thyroid cancers, pituitary and adrenal gland disorders, and hormone imbalances. He graduated from Cerrahpaşa School of Medicine, Istanbul University in 1999. He completed his internal medicine residency in 2005 and his endocrinology fellowship in 2010.

Dr. Ipekci became an Associate Professor in 2016. He has published 42 international scientific articles. His research has been cited 230 times. He has contributed to 8 national and international scientific projects, including 2 TUBITAK projects. He has received several awards for his scientific publications. Dr. Ipekci has also served as a referee for 65 articles. His work demonstrates his strong commitment to medical science.

Dr. Suleyman Hilmi Aksoy was born in 1974. He graduated from Istanbul University Çapa School of Medicine in 1998. He completed his residency in Radiodiagnostics and Interventional Radiology at Cerrahpaşa School of Medicine in 2002.

He has given oral and written presentations at 13 local and international congresses. Dr. Aksoy specializes in Diagnostic Radiology, Teleradiology, and Interventional Radiology. He has made important contributions in these areas.

He has worked at Hisar Intercontinental Hospital, Merzifon Air Hospital, Istanbul Emar Center, and Haseki Training and Research Hospital. Dr. Aksoy is dedicated to improving radiological practices.

Dr. Zuhal Tanzer is a specialist in Internal Diseases. She is known for her skill in diagnosing and treating complex medical conditions. Dr. Tanzer has a strong record of patient satisfaction and successful treatments. She is accredited by top medical institutions. She also takes part in ongoing medical education. Dr. Tanzer uses evidence-based methods and is dedicated to improving standards in internal medicine.

Dr. Sertkaya graduated from Konya Meram Science High School in 2001 and entered Gazi University Medical Faculty the same year, graduating in 2008. He completed his urology specialization at Haydarpaşa Numune Training and Research Hospital in 2014, becoming a urology specialist.

Since becoming a specialist, he has focused on the sub-branch of Andrology, attending various training sessions and conferences and performing surgeries with some of the world's leading Andrology professors. In 2017, he passed the written and oral proficiency exams conducted by the European Association of Urology, earning the title of "FEBU."

In 2020, Dr. Sertkaya achieved the rank of Associate Professor of Urology. His journey in Urology and Andrology, which began in 2008, continues at the Andro Expertise Male Health and Aesthetics Center, which he founded in 2022. He sees patients in his own clinic and performs surgeries at affiliated hospitals.

Dr. Hilmi Cem Kaya is an experienced ENT specialist. He earned his medical degree from Ege University Faculty of Medicine. He completed his ENT specialization at Uludağ University. Both universities are well-known for their strong medical programs.

Dr. Kaya has worked at top hospitals in Turkey. He served at Sultan Abdulhamid Han Training and Research Hospital in 2023. He also worked at Martyr Prof. Dr. İlhan Varank Sancaktepe Training and Research Hospital from 2021 to 2022. During this time, he gained skills in advanced surgical techniques and patient care.

He is known for his expertise in modern, minimally invasive ENT treatments. Dr. Kaya achieves high success rates in his treatments. He stays up to date with the latest research and training to provide the best care for his patients.

Education and Career

2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

Medicine Department of Internal Medicine

2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

Memberships in Scientific Organizations

ASCO

ESMO

TTOD 

AVOD 

Publications

In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

Awards Received

EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

Speeches Delivered at National Congresses, Conferences, and Symposia:

Courses, Meetings, and Certificates

ESMO certified Medical Oncologist since 2019

Prof. Dr. Ayla Güven graduated from Gazi University Faculty of Medicine in 1986 and completed her mandatory service at Ege University Chest Diseases Bornova Tuberculosis Dispensary. Following that, she started her specialization training in the Department of Child Health and Diseases at Hacettepe University Faculty of Medicine and became a specialist in 1993. After working as a specialist physician, she began her subspecialty training in Pediatric Endocrinology at Gazi University Faculty of Medicine in September 2000 and became a Pediatric Endocrinology specialist in December 2002. In April 2003, she started working as an assistant professor at Ondokuz Mayıs University Faculty of Medicine and worked in the Pediatric Endocrinology and Diabetes Department at the Children’s Hospital of Pittsburgh, USA, between May and November 2003. After returning to Turkey, she continued to work at Ondokuz Mayıs University Faculty of Medicine. This clinic was the first to offer Pediatric Endocrinology subspecialty training in the country. During her time there, one person became a Pediatric Endocrinology specialist. On March 13, 2006, she successfully passed the exam and received the title of Associate Professor. Since December 2006, she has been working at Göztepe Training and Research Hospital. In this hospital, she was appointed as the head of the Pediatric Endocrinology clinic in November 2008 and started providing Pediatric Endocrinology subspecialty training for the first time in the hospital in March 2009. Between 2009 and 2017, she trained five Pediatric Endocrinology specialists. Most of the physicians she currently provides subspecialty training to have gained academic titles as professors and associate professors. After working as a training instructor at Health Sciences University Zeynep Kamil Hospital for Children and Women from 2017 to 2021, she retired at her request from public service. Between 2021 and 2024, she worked as a Pediatric Endocrinology specialist at Başkent University Faculty of Medicine, Department of Child Health and Diseases, at Istanbul Hospital.

MEDICAL INTERESTS

• Menstrual disorders and increased hair growth in girls, polycystic ovary syndrome
• Adrenal diseases
• Sexual development disorders
• Type 2 diabetes
• Thyroid diseases
• Growth disorders: short stature and tall stature
• Puberty disorders: precocious puberty-delayed puberty

Dr. Saban Sec is a medical oncologist with experience at leading hospitals, including Haseki Training and Research Hospital, Prof. Dr. Cemil Taşcıoğlu City Hospital, and Bahçelievler Medikalpark Hospital. He currently represents specialist physicians in the Turkish Medical Oncology Association. He is also a member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association.

Dr. Sec treats breast, lung, gastrointestinal, prostate, urogenital, head and neck cancers, as well as sarcomas and rare tumors. He has published many peer-reviewed articles on cancer prognosis, treatment outcomes, and survival rates. His research includes studies with large patient groups, such as 138 patients with HER2-positive metastatic gastric cancer. Dr. Sec focuses on prognostic factors and treatment responses in different cancers. He is dedicated to improving cancer care.

Education and Expertise

(1994 – 2000) - GATA Faculty of Medicine Ankara

(2003 – 2007) - GATA Medical Faculty Pediatrics and Diseases

(2008 -2011) - Ankara University Pediatric Endocrinology

(03.03.2014) - Associate Professorship, Pediatric Endocrinology

(17.07.2019) - Professorship, Istinye University Faculty of Medicine

Experience

(2001 – 2003) - Special Forces Command/Ankara

(2007 – 2008) - Etimesgut Military Hospital/Ankara

(2011 – 2013) - GATA Medical Faculty Hospital/Ankara

(2013-2015) - GATA Haydarpasa Training Hospital/Istanbul

(05.2015-09.10.2017) - May 2015-09.10.2017 - Süleymaniye Gynecology and Pediatrics Training and Research Hospital/Istanbul

(07.2015 – 01.2016) - Suleymaniye Gynecology and Pediatrics Training and Research Hospital Pediatrics Administrative Responsibility/Istanbul

01.2016 - 09.11.2017 - Suleymaniye Gynecology and Pediatrics Training and Research Hospital Pediatric Clinic Education Responsibility / Istanbul

(03.03.2016 - 30.10.2017) - Süleymaniye Gynecology and Pediatrics Training and Research Hospital Management

(2017-2020) - Istinye University Faculty of Medicine Faculty Member

(2020-Present) - Istanbul Aydın University Faculty of Medicine Faculty Member

(20.10.2020-Present) - Head of Department of Child Health and Diseases, Faculty of Medicine, Istanbul Aydın University

Courses and Certificates

2001 - Flight Doctor Course

2010 - Project Management Training Course

2013 - Basic Epidemiology course

2018 - Trainer Training Course

Professional Memberships

Pediatric Endocrinology and Diabetes Association

European Society of Pediatric Endocrinology (ESPE)

Istanbul Medical Chamber

Awards

İhsan Turan, Ian Hutchins, Bülent Hacıhamdioğlu, Leman Damla Kotan, Fatih Gürbüz, Mehmet Taştan, Ayça Ulubay, Eda Mengen, Bilgin Yüksel, Susan Wray, Ali Kemal Topaloğlu. CCDC141 Mutation in idiopathic hypogonadotropic hypogonadism. XVI. First Prize in Oral Presentation at the National Pediatric Endocrine and Diabetes Congress.

Bülent Hacıhamdioğlu, Gönül Öçal, Merih Berberoğlu, ZeynepŞıklar, Ercan Tutar, Suat Fitöz, Gökhan Nergizoğlu, Şenay Savaş Erdeve, Emine Çamtosun. Control of premature microvascular aging and cardiovascular performance in obese adolescents. XVI. was held in Samsun on 6-10 November 2012. Second Prize in Oral Presentation at the National Pediatric Endocrine and Diabetes Congress.

Z. Siklar, G. Ocal, M. Berberoglu, B. Hacıhamdioğlu, Ş. Savas Erdeve, Y. Egin, N. Akar. Control of hypercoagulability caused by obesity in children with endothelial microparticle level and thrombin generation test, and the relationship between risk and metabolic parameters. First Prize in Oral Presentation at the 55th Turkish National Pediatrics Congress held in Antalya on 12-16 October 2011

Z. Şıklar, V. Topçu, P. Kocaay, M. Berberoğlu, B. Hacıhamdioğlu, S.S. Erdeve, H.R. Ilgin, A. Tükün, G. Öcal. Clinical Characteristics of Our Cases with Mutation in the Androgen Receptor Gene. XVI. was held in Samsun on 6-10 November 2012. First Prize in Oral Presentation at the National Pediatric Endocrine and Diabetes Congress.

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

Education and Experience

• 1992 - 1998, Gaziantep University, Faculty of Medicine
• 2002 – 2015, Cumhuriyet University, Faculty of Medicine, Department of Internal Medicine
• 2015 – 2024, Bağcılar Medipol Mega University Hospital
• 2024 – Present, Medipol Acıbadem Hospital

Medical Interests and Activities 

• Internal Diseases, Endocrinology and Metabolic Diseases 

• Diabetes 

• Thyroid Diseases 

• Pituitary Gland Diseases 

• Adrenal Gland Diseases 

• Osteoporosis and Metabolic Bone Diseases 

• Female and Male Reproductive System Diseases 

Educational Background 

• Cerrahpaşa Medical School, 1997 

• Assistant Education for Internal Medicine Haydarpaşa Numune Hospital, 2003 

• Education for Endocrine and Metabolic Diseases: Cerrahpaşa Medical School, 2008 

Professional Experience 

• Göztepe Research & Training Hospital, 2008 - 2010 (mandatory service) 

• Bayındır Hospital, 2010 - 2014 

• Kolan İnternational Hospital, 2014 - 2018 Memberships 

• Turkish Association of Endocrinology and Metabolism 

• Turkish Society of Diabetes 

• European society of Anesthesiology 

• European Association for the Study of Diabetes 

Researches and Publications 

• International articles: 20; national articles: 20; international papers: 15; national papers: 18 Translation of 5 book sections

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Education

• 1986-1989, Bursa High School, Bursa, Turkey
• 1989-1995, Istanbul University, Istanbul School of Medicine, Turkey
• 1999-2003, (Residency) Kadir Has University, School of Medicine, Department of Radiation Oncology, Istanbul, Turkey
• 2015, (Associate Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

Experience

• 1995-1999, Şişli Florence Nightingale Hospital, Istanbul, Cardiology Department
• 2003, Gayrettepe Florence Nightingale Hospital, Istanbul, Department of Radiation Oncology
• 2015, (Associate Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

Education

• Undergraduate: Çukurova University, Faculty of Medicine 1992-1998
• Specialty Education: Istanbul Training and Research Hospital 1998-2003
• Subspecialization: IU Istanbul Faculty of Medicine 2004-2007
•  

Experience

• Istanbul Training and Research Hospital 1998-2003
• IU Istanbul Faculty of Medicine 2004-2007
• Istanbul Training and Research Hospital 2007-2009
• Şanlıurfa Training and Research Hospital 2009-2011
• Bağcılar Training and Research Hospital August 2011- November 2011
• Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolic Diseases December 2011- 2014
• Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolic Diseases 2014-2020
• Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolic Diseases 2020-2024

Scientific Memberships
 

• Turkish Society of Endocrinology and Metabolic Diseases (Vice President)
• European Society of Endocrinology;
• Endosociety

Awards

1. 1. Bestclinical scientific publication support award (53rd National Diabetes Congress, 2017)
2. 2. 54th National Diabetes Congress (2018) with the study titled "The effects of adding pre-probiotics to the diets of patients with gastric bypass (GBP) on metabolic parameters, icretin levels and hunger, satiety and appetite scores of patients".

Medical Intrests

• Diabetes
• Thyroid diseases (hypothyroidism, hyperthyroidism, thyroid nodules)
• Pituitary diseases
• Adrenal gland diseases
• Osteoporosis

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Dr. Gonul Catli is a pediatric endocrinologist with over 20 years of experience. She specializes in childhood hormonal and metabolic disorders. Her areas of focus include diabetes, thyroid diseases, growth problems, and puberty issues. She received her training at Ankara University and Dokuz Eylul University. Dr. Catli has also worked as an Associate Professor at Izmir Katip Celebi University.

Dr. Catli is known for her scientific work and caring approach. She currently practices at Liv Hospital Ulus and Vadistanbul. She is a member of the European Society of Pediatric Endocrinology (ESPE) and several national associations. Dr. Catli is dedicated to using new treatments to support children’s health and well-being.